SIGMAR1 and Alpha-thalassemia - X-linked intellectual disability syndrome: Here, we show that Sig-1R activation with SA4503, a potent activator of Sig-1R [32], features potential as a therapeutic intervention for diminished cognitive function in ATR-X syndrome.